Orange Book product · Generic (ANDA)
CYANOCOBALAMIN
CYANOCOBALAMIN
At a glance
Nov 15, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 15, 2022
3 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CYANOCOBALAMIN
Strength
1MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215107
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CYANOCOBALAMIN
- 2007CALOMISTBrand (NDA)
NDA 022102 · PH HEALTH
- 2005NASCOBALBrand (NDA)
NDA 021642 · ENDO OPERATIONS
- 1996NASCOBALBrand (NDA)
NDA 019722 · ENDO OPERATIONS
- —BERUBIGENBrand (NDA)
NDA 006798 · PHARMACIA AND UPJOHN
- —CYANOCOBALAMINBrand (NDA)
NDA 007085 · WARNER CHILCOTT
- —REDISOLBrand (NDA)
NDA 006668 · MERCK
- —RUBIVITEBrand (NDA)
NDA 010791 · BEL MAR
- —RUBRAMIN PCBrand (NDA)
NDA 006799 · BRISTOL MYERS SQUIBB
- —VI-TWELBrand (NDA)
NDA 007012 · BAYER HLTHCARE
- 2024CYANOCOBALAMINGeneric (ANDA)
ANDA 214316 · MEITHEAL
- 2024CYANOCOBALAMINGeneric (ANDA)
ANDA 217839 · MANKIND PHARMA
- 2023CYANOCOBALAMINGeneric (ANDA)
ANDA 210629 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
